Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer

Nicolò Matteo Luca Battisti, María Sol Andrés, Karla A. Lee, Sivatharshini Ramalingam, Tamsin Nash, Stephanie Mappouridou, Nishanthi Senthivel, Kalaprapa Asavisanu, Mariam Obeid, Elli‐Sophia Tripodaki, Vasileios Angelis, Emily Fleming, E. Goode, Susan John, Stuart D. Rosen, Mark Allen, Susannah Stanway, Alexander R. Lyon, Alistair Ring